Intezyne Archives - Inside Precision Medicine

Inside Precision Medicine Exosome Diagnostics, Intezyne Partner on CDx for Cancer Treatment IT-139

Exosome Diagnostics is partnering with Intezyne to design and validate a companion diagnostic for the drug developer’s upcoming Phase I/II clinical trials of its cancer treatment IT-139. [National Center for Advancing Translational Sciences (NCATS)

Molecular Dx

Exosome Diagnostics, Intezyne Partner on CDx for Cancer Treatment IT-139

March 16, 2018

Related Content

Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine

Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine

New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease

New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease

Colorectal Cancer Progression Linked to Circadian Disruption and Gut Microbiome Changes

Colorectal Cancer Progression Linked to Circadian Disruption and Gut Microbiome Changes

Cause of Drusen-Forming Macular Degeneration Uncovered

Cause of Drusen-Forming Macular Degeneration Uncovered